US, EU Regulators Ban GSK's Avandia In Most Cases

By Julie Zeveloff · September 23, 2010, 12:04 PM EDT

Drug regulators in the U.S. and Europe said Thursday that they would drastically restrict availability of GlaxoSmithKline PLC's diabetes medication Avandia in response to evidence that the drug could cause heart...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Julie

October 13, 2010
Cobalt Released From Sepracor Suit Over Sleep Drug
October 07, 2010
Pfizer Recalls 191,000 Lipitor Bottles Due To Odor
October 07, 2010
Endo, Watson Settle Litigation Over Opana ER Generic
October 05, 2010
Teva Sues Mylan, Others Over Proposed Azilect Generic
September 30, 2010
Novartis Contact Lens Patent Invalid, UK Court Affirms
August 11, 2010
Conceptus Falsely Marked Sterilization Kit, Rival Says
July 27, 2010
St. Jude Goes After Volcano Over Guide Wire Patents
July 26, 2010
Wyeth Bests Pa. Fen-Phen Hypertension Suit
July 16, 2010
King Pharma Sues Sandoz Over Generic EpiPen
July 15, 2010
Latham Reps Carlyle Group In $3.8B NBTY Acquisition